Bisphosphonate
Bisphosphonate has been studied in 3 papers since 1993: 1 observational study in people, 2 reviews.
12 new papers in 30 daysSee all 258
“Worse scores of FRAX® and the Garvan tool were associated with use of bisphosphonate for short-term fracture prevention in primary GIO”
- 1 lab in 1 country
- 2 trials, none about aging
- Funders: National Institute of Arthritis and Musculoskeletal and Skin Diseases and 2 more
- Humans1
What is Bisphosphonate linked with?
1Studies link Bisphosphonate with 1 measure, most often FRAX (1 study).
FRAX
upin humans1
1 study
FRAX
upin humans1
FRAX is associated with bisphosphonate in humans.
“Worse scores of FRAX® and the Garvan tool were associated with use of bisphosphonate for short-term fracture prevention in primary GIO”
Humansduring initial prednisolone loading in elderly ITP patientsn = 22
Research SquarePreprint
Who is developing Bisphosphonate?
2 companies: Ultragenyx Pharmaceutical and Amgen.
Trial sponsors
Company1 trialPhase 3111 people
Company1 trialPhase 369 people
Funding
5 grants since 2019National Institute of Arthritis and Musculoskeletal and Skin DiseasesUS$7.7mNational Institute on AgingUS$7.1mNational Institute for Health Research£490.5k
Pooling International Cohort Studies of Long-Term Bisphosphonate Use and Atypical Femur Fractures
National Institute of Arthritis and Musculoskeletal and Skin DiseasesUniversity of California, San FranciscoUS$127.5k2022–2027
Exercise and Bisphosphonate Use to Minimize Weight Loss Associated Bone Loss among Older Adults
National Institute on AgingWake Forest UniversityUS$1.5m2022–2027
National Institute of Arthritis and Musculoskeletal and Skin DiseasesCity College of New YorkUS$482k2023–2029
National Institute of Arthritis and Musculoskeletal and Skin DiseasesUniversity of California, San FranciscoUS$486.5k2016–2023
National Institute for Health ResearchNottingham University Hospitals NHS Trust£490.5k2019–2022